Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports. [electronic resource]
- Future oncology (London, England) 2015
- 1223-32 p. digital
Publication Type: Case Reports; Journal Article; Review
1744-8301
10.2217/fon.14.318 doi
Aged Antineoplastic Combined Chemotherapy Protocols--therapeutic use ErbB Receptors--antagonists & inhibitors Female Histone Deacetylase Inhibitors--therapeutic use Humans Lapatinib Molecular Targeted Therapy Neoplasms, Glandular and Epithelial--drug therapy Niacinamide--administration & dosage Phenylurea Compounds--administration & dosage Pleural Neoplasms--drug therapy Protein Kinase Inhibitors--therapeutic use Proto-Oncogene Proteins c-kit--antagonists & inhibitors Quinazolines--administration & dosage Receptor, IGF Type 1 Receptors, Somatomedin--antagonists & inhibitors Sorafenib TOR Serine-Threonine Kinases--antagonists & inhibitors Thymus Neoplasms--drug therapy Young Adult